Key result
Shortest PV-FARS10 ≤155 ms predicts lower AF/AFL/AT recurrence after PVI.
Why the study?
Does a shortest PV-FARS10 ≤ 155 ms predict reduced atrial arrhythmia recurrence in patients undergoing first pulmonary vein isolation for atrial fibrillation?
Cohort (n=219)
No
Does a shortest PV-FARS10 ≤ 155 ms predict reduced atrial arrhythmia recurrence in patients undergoing first pulmonary vein isolation for atrial fibrillation?
Measuring the shortest pulmonary vein atrial fibrillation cycle length (PV-FARS10 ≤ 155 ms) accurately identifies patients with paroxysmal or persistent AF who are more likely to remain free from arrhythmia recurrence after a PVI-only approach.
Hypothesis-generating for PV-FARS10 to select PVI responders in AF; requires prospective trials before clinical adoption.
AIMS: Atrial fibrillation cycle length (AF-CL) measured in the pulmonary veins (PVs) with a novel simple method [the average of the 10 consecutive Fastest Atrial Repetitive Similar signal interval (FARS10)] accurately identified pulmonary vein isolation (PVI) responders in a preliminary study. This study aims to evaluate differences in PV-FARS10 between paroxysmal and persistent AF and to define the optimal cut-off to predict PVI-only approach success in a large population. METHODS AND RESULTS: We prospectively enrolled consecutive patients with persistent or paroxysmal AF undergoing first PVI in a single-centre study. The primary endpoint was atrial arrhythmia recurrence. A total of 219 patients (61.8 ± 11.2 years, 25.1% female) were included, with 70 patients (32%) having paroxysmal AF and 149 patients (68%) persistent AF. After a median follow-up of 18.0 [interquartile range (IQR) 10.2-42.3] months, 72 (32.9%) patients experienced AF/atrial flutter (AFL)/atrial tachycardia (AT) recurrence. Patients with shortest PV-FARS10 ≤ 155 ms had a lower rate of AF/AFL/AT recurrence compared to those with shortest PV-FARS10 > 155 ms in the overall population (HR 0.34, P < 0.001), in persistent AF (HR 0.40, P = 0.002), and in paroxysmal AF (HR 0.18, P = 0.01). In multivariable analysis-which included age, sex, body mass index, CHA2DS2-VA score, obstructive sleep apnoea syndrome, duration of AF, AF type (paroxysmal vs. persistent), left ventricular ejection fraction, left atrial volume index, shortest PV-FARS10/left atrial appendage-FARS10, and AF termination during ablation-only the shortest PV-FARS10 ≤ 155 ms was the significant predictor of AF/AFL/AT recurrence-free survival in the overall population (HR 0.45, CI: 0.26-0.78, P = 0.005). Paroxysmal AF patients more frequently had shortest PV-FARS10 ≤ 155 ms than persistent AF patients (61.4% vs. 42.3%, P = 0.009). CONCLUSION: PV-FARS10 can accurately identify PVI responders among patients with persistent and paroxysmal AF. Patients with slow PV (shortest PV-FARS10 > 155 ms) experience a higher rate of AF/AFL/AT recurrence after PVI-only approach. The shortest PV-FARS10 ≤ 155 ms occurs more frequently in paroxysmal AF patients than in persistent AF patients.
No takes yet. Share an insight, caveat, or question.
Marcon et al. (2026) conducted a cohort in Persistent or paroxysmal atrial fibrillation (n=219). Shortest PV-FARS10 ≤ 155 ms vs. Shortest PV-FARS10 > 155 ms was evaluated on Atrial arrhythmia recurrence (HR 0.45, 95% CI 0.26-0.78, p=0.005). A shortest PV-FARS10 ≤ 155 ms was associated with a significantly lower risk of atrial arrhythmia recurrence after pulmonary vein isolation (HR 0.45; 95% CI 0.26-0.78; P=0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: